A detailed history of Mercer Global Advisors Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 14,198 shares of BBIO stock, worth $367,444. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,198
Previous 14,271 0.51%
Holding current value
$367,444
Previous $441,000 18.59%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$23.0 - $31.04 $1,679 - $2,265
-73 Reduced 0.51%
14,198 $359,000
Q1 2024

May 15, 2024

BUY
$27.35 - $40.45 $2,707 - $4,004
99 Added 0.7%
14,271 $441,000
Q4 2023

Feb 14, 2024

BUY
$24.02 - $43.89 $1,417 - $2,589
59 Added 0.42%
14,172 $572,000
Q2 2023

Aug 14, 2023

BUY
$13.29 - $18.01 $48,016 - $65,070
3,613 Added 34.41%
14,113 $242,000
Q1 2023

May 15, 2023

SELL
$7.17 - $18.55 $279 - $723
-39 Reduced 0.37%
10,500 $174,000
Q3 2022

Nov 15, 2022

BUY
$7.94 - $12.36 $83,679 - $130,262
10,539 New
10,539 $105,000

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.84B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.